gatifloxacin has been researched along with eye in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitterman, A; Chruscicki, DA; Cohn, S; Donnenfeld, E; Perry, HD; Solomon, R | 1 |
| Guo, H; Li, J; Liu, Z; Nie, S; Pan, W | 1 |
| Blondeau, JM; Hedlin, P | 1 |
| Ahmad, FJ; Chopra, S; Khar, RK; Kohli, K; Motwani, SK; Talegaonkar, S | 1 |
| Li, J; Li, X; Liu, Z; Pan, W; Yang, XG | 1 |
| Kozai, S; Ohashi, Y; Sakaki, H; Suzuki, T; Tajika, T; Wada, T | 1 |
| Bai, XQ; Deng, SJ; Li, L; Li, R; Liang, QF; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Choi, JS; Joo, CK; Kim, KA; Lim, JA; Park, SH | 1 |
| Hosny, KM | 1 |
| Kobayakawa, S; Ooki, K; Tochikubo, T; Tsuji, A | 1 |
| Kida, T; Kozai, S; Ohtori, A; Sakaki, H; Tajika, T; Wada, T | 1 |
| El-Leithy, IS; Ibrahim, HK; Makky, AA | 1 |
| Davis, LT; Fiscella, RG; Glickman, RD; Kumar, N; Nijm, LM; Peterson, RJ; Tu, EY; Ulanski, LJ | 1 |
| Proksch, JW; Ward, KW | 1 |
| Chen, H; Jiang, H; Liu, T; Song, Z; Wu, X; Xu, Y; Yang, L; Yue, W | 1 |
| Chen, ZJ; Han, L; Sun, ST; Wang, LY; Yue, J; Zhang, YQ | 1 |
| Kadam, RS; Kompella, UB; Vooturi, SK | 1 |
| Abul Kalam, M; Ali, A; Aljuffali, IA; Alshamsan, A; Aqil, M; Mishra, AK; Sultana, Y | 1 |
| Al-Kassas, R; Deo, S; Duxfield, L; Englebretsen, V; Rupenthal, I; Sultana, R; Swift, S; Wang, R | 1 |
| Chen, S; Lu, H; Shen, X; Wang, M; Zhang, X; Zhao, X | 1 |
1 trial(s) available for gatifloxacin and eye
| Article | Year |
|---|---|
A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
Topics: Adult; Anterior Chamber; Aza Compounds; Conjunctiva; Eye; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperemia; Irritants; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pain; Pupil; Quinolines | 2004 |
19 other study(ies) available for gatifloxacin and eye
| Article | Year |
|---|---|
Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes.
Topics: 1-Octanol; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cornea; Drug Carriers; Enoxacin; Ethylene Glycols; Eye; Fluoroquinolones; Gatifloxacin; In Vitro Techniques; Irritants; Levofloxacin; Ofloxacin; Oxaprozin; Permeability; Propionates; Rabbits; Ribavirin; Water | 2006 |
Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.
Topics: Anti-Infective Agents; Antimutagenic Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Osmolar Concentration; Quinolines | 2007 |
Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
Topics: Administration, Topical; Alginates; Chemistry, Pharmaceutical; Chitosan; Eye; Fluoroquinolones; Gatifloxacin; Glucuronic Acid; Hexuronic Acids; Microscopy, Electron, Transmission; Nanoparticles; Pharmaceutical Vehicles; Solubility | 2008 |
Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis.
Topics: Animals; Biological Availability; Drug Delivery Systems; Eye; Fluoroquinolones; Gatifloxacin; Gels; Microdialysis; Rabbits | 2007 |
Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Biological Availability; Disease Progression; Endophthalmitis; Enterococcus faecalis; Eye; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Male; Ofloxacin; Ointments; Ophthalmic Solutions; Quinolones; Rabbits | 2008 |
[Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Eye; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacteria, Aerobic; Ciprofloxacin; Conjunctiva; Eye; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2009 |
Optimization of gatifloxacin liposomal hydrogel for enhanced transcorneal permeation.
Topics: Administration, Topical; Amines; Animals; Biological Availability; Chemistry, Pharmaceutical; Cholesterol; Eye; Fluoroquinolones; Gatifloxacin; Hydrogel, Polyethylene Glycol Dimethacrylate; Liposomes; Phosphatidylcholines; Rabbits | 2010 |
Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Cataract Extraction; Drug Administration Schedule; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Models, Animal; Moxifloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Surgical Wound Infection | 2009 |
Effect of dosing interval on the efficacy of topical ophthalmic gatifloxacin against Enterococcus faecalis in an in vitro pharmacokinetic model simulating the local eye compartment.
Topics: Administration, Topical; Anti-Bacterial Agents; Colony Count, Microbial; Enterococcus faecalis; Eye; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Microbial Viability; Models, Theoretical; Time Factors | 2009 |
Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy.
Topics: Animals; Calorimetry, Differential Scanning; Eye; Fluoroquinolones; Gatifloxacin; Hyaluronic Acid; Kinetics; Nanoparticles; Prednisolone; Rabbits; Spectroscopy, Fourier Transform Infrared | 2010 |
An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Aza Compounds; Cefuroxime; Chromatography, High Pressure Liquid; Contact Lenses, Hydrophilic; Eye; Fluoroquinolones; Gatifloxacin; Linear Models; Linezolid; Moxifloxacin; Oxazolidinones; Quinolines; Rabbits; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Vitreous Body | 2010 |
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Area Under Curve; Aza Compounds; Azepines; Conjunctivitis, Bacterial; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections | 2010 |
Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents, Local; Colony Count, Microbial; Conjunctival Diseases; Cornea; Eye; Female; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Keratitis; Levofloxacin; Male; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2012 |
[The changes of ocular bacterial isolates and in vitro antimicrobial susceptibility in the past six years].
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus epidermidis; Tobramycin | 2012 |
Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
Topics: Administration, Topical; Animals; Biological Transport; Chromatography, Liquid; Drug Delivery Systems; Eye; Fluoroquinolones; Gatifloxacin; Monocarboxylic Acid Transporters; Organic Cation Transport Proteins; Permeability; Prodrugs; Rabbits; Solubility; Tandem Mass Spectrometry; Tissue Distribution | 2012 |
Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Topics: Calorimetry, Differential Scanning; Drug Delivery Systems; Drug Stability; Eye; Fluoroquinolones; Gatifloxacin; Lipids; Nanoparticles; Particle Size; Regression Analysis; Reproducibility of Results; Rheology; Static Electricity; Statistics as Topic; Suspensions; X-Ray Diffraction | 2013 |
Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
Topics: Anti-Infective Agents; Bacteria; Biological Availability; Cations; Cells, Cultured; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Emulsions; Eye; Fluoroquinolones; Gatifloxacin; Humans; Nanoparticles; Particle Size; Polymers; Polysorbates; Surface-Active Agents | 2016 |
Comparative Study of Ocular Pharmacokinetics of Gatifloxacin Between Continuous Lavage and Hourly Topical Instillation in Rabbits.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Area Under Curve; Eye; Fluoroquinolones; Gatifloxacin; Models, Animal; Ophthalmic Solutions; Rabbits; Therapeutic Irrigation; Tissue Distribution | 2018 |